Medelis is a specialty oncology CRO based in Nashville, TN, offering a comprehensive range of services for oncology drug development. Led by a highly-skilled clinical team and thought-leaders in oncology, Medelis provides expertise in pioneering immunotherapy treatments and deep operational experience in oncology studies. With extensive investigator relationships, Medelis ensures quick study launch and proper site selection, crucial for success in the rapidly expanding field of cancer immunotherapy. As a partner by your side, Medelis prioritizes relationships, making the right decisions, and providing streamlined trial planning and management to deliver the results you need.
With a focus on delivering accurate results quickly, Medelis differentiates itself as a specialty oncology CRO. The company offers deep oncology expertise at every level of your trial, a flexible and collaborative approach to integrate with your team, world-class drug development expertise, and transparent bidding for cost savings and cost certainty. With over 20 years of experience in oncology indications, covering 3 continents and completing 150 projects, Medelis is equipped to create and implement detailed drug development plans, provide flexible resourcing, conduct rescue studies, offer drug development consulting, and assist non-U.S.-based companies in gaining access to the U.S. drug study market.
Generated from the website